Comparison between Emcure Pharmaceuticals IPO and Vraj Iron IPO.
Emcure Pharmaceuticals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Vraj Iron IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Emcure Pharmaceuticals IPO is up to ₹1,952.03 Cr whereas the issue size of the Vraj Iron IPO is up to ₹171.00 Cr. The final issue price of Emcure Pharmaceuticals IPO is ₹1,008.00 per share and of Vraj Iron IPO is ₹207.00 per share.
| Emcure Pharmaceuticals IPO | Vraj Iron IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹960.00 per share | ₹195.00 per share |
| Issue Price (Upper) | ₹1,008.00 per share | ₹207.00 per share |
| Issue Price (Final) | ₹1,008.00 per share | ₹207.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹90.00 per share | |
| Market Lot Size | 14 shares | 72 shares |
| Fresh Issue Size | 79,46,231 shares | 82,60,869 shares |
| Fresh Issue Size (Amount) | up to ₹800.58 Cr | up to ₹171.00 Cr |
| OFS Issue Size | 1,14,28,839 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹1,151.45 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,93,75,070 shares | 82,60,869 shares |
| Issue Size Total (Amount) | up to ₹1,952.03 Cr | up to ₹171.00 Cr |
Emcure Pharmaceuticals IPO opens on Jul 03, 2024, while Vraj Iron IPO opens on Jun 26, 2024. The closing date of Emcure Pharmaceuticals IPO and Vraj Iron IPO is Jul 05, 2024, and Jun 28, 2024, respectively.
| Emcure Pharmaceuticals IPO | Vraj Iron IPO | |
|---|---|---|
| Anchor Bid Date | Jul 02, 2024 | Jun 25, 2024 |
| Issue Open | Jul 03, 2024 | Jun 26, 2024 |
| Issue Close | Jul 05, 2024 | Jun 28, 2024 |
| Basis Of Allotment (Tentative) | Jul 08, 2024 | Jul 01, 2024 |
| Initiation of Refunds (Tentative) | Jul 09, 2024 | Jul 02, 2024 |
| Credit of Share (Tentative) | Jul 09, 2024 | Jul 02, 2024 |
| Listing date (Tentative) | Jul 10, 2024 | Jul 03, 2024 |
| Anchor Lockin End date 1 | Aug 07, 2024 | Jul 31, 2024 |
| Anchor Lockin End date 2 | Oct 06, 2024 | Sep 29, 2024 |
Emcure Pharmaceuticals IPO P/E ratio is 34.55, as compared to Vraj Iron IPO P/E ratio of 9.48.
| Emcure Pharmaceuticals IPO | Vraj Iron IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.21 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 78.08 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 34.55 | 9.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹19029.89 Cr. | ₹682.74 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 16.90% | 23.78% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 19.37% | 25.34% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.67 | 0.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹29.17 | ₹21.84 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 16.87% | 23.78% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Emcure Pharmaceuticals IPO Retail Individual Investors (RII) are offered 67,43,160 shares while in Vraj Iron IPO retail investors are offered 67,43,160 shares. Qualified Institutional Buyers (QIB) are offered 38,53,234 shares in Emcure Pharmaceuticals IPO and 16,52,174 shares in Vraj Iron IPO.
| Emcure Pharmaceuticals IPO | Vraj Iron IPO | |
|---|---|---|
| Anchor Investor Reservation | 57,79,850 shares | 24,78,259 shares |
| Market Maker Reservation | ||
| QIB | 38,53,234 shares | 16,52,174 shares |
| NII | 28,89,926 shares | 12,39,131 shares |
| RII | 67,43,160 shares | 28,91,305 shares |
| Employee | 1,08,900 shares | |
| Others | ||
| Total | 1,93,75,070 shares | 82,60,869 shares |
Emcure Pharmaceuticals IPO subscribed 67.87x in total, whereas Vraj Iron IPO subscribed 126.36x.
| Emcure Pharmaceuticals IPO | Vraj Iron IPO | |
|---|---|---|
| QIB (times) | 191.24x | 173.99x |
| NII (times) | 49.32x | 221.66x |
| Big NII (times) | 54.90x | 217.50x |
| Small NII (times) | 38.16x | 229.99x |
| RII (times) | 7.36x | 58.31x |
| Employee (times) | 8.81x | |
| Other (times) | ||
| Total (times) | 67.87x | 126.36x |
